Carnegie Investment Counsel’s iShares Global Healthcare ETF IXJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $251K | Buy |
2,550
+400
| +19% | +$37.6K | 0.01% | 511 |
|
|
2026
Q1 | $201K | Sell |
2,150
-351
| -14% | -$34.4K | ﹤0.01% | 550 |
|
|
2025
Q4 | $244K | Hold |
2,501
| – | – | ﹤0.01% | 519 |
|
|
2025
Q3 | $222K | Buy |
+2,501
| New | +$216K | ﹤0.01% | 526 |
|
|
2024
Q4 | – | Sell |
-2,150
| Closed | -$211K | – | 474 |
|
|
2024
Q3 | $211K | Buy |
+2,150
| New | +$208K | 0.01% | 451 |
|
|
2024
Q2 | – | Sell |
-2,150
| Closed | -$200K | – | 489 |
|
|
2024
Q1 | $200K | Buy |
+2,150
| New | +$195K | 0.01% | 485 |
|
|
2023
Q4 | – | Sell |
-3,000
| Closed | -$247K | – | 493 |
|
|
2023
Q3 | $247K | Hold |
3,000
| – | – | 0.01% | 445 |
|
|
2023
Q2 | $255K | Hold |
3,000
| – | – | 0.01% | 449 |
|
|
2023
Q1 | $250K | Hold |
3,000
| – | – | 0.01% | 460 |
|
|
2022
Q4 | $255K | Hold |
3,000
| – | – | 0.01% | 448 |
|
|
2022
Q3 | $226K | Hold |
3,000
| – | – | 0.01% | 437 |
|
|
2022
Q2 | $243K | Hold |
3,000
| – | – | 0.01% | 428 |
|
|
2022
Q1 | $263K | Hold |
3,000
| – | – | 0.01% | 430 |
|
|
2021
Q4 | $271K | Hold |
3,000
| – | – | 0.01% | 431 |
|
|
2021
Q3 | $251K | Hold |
3,000
| – | – | 0.01% | 423 |
|
|
2021
Q2 | $249K | Hold |
3,000
| – | – | 0.01% | 424 |
|
|
2021
Q1 | $231K | Hold |
3,000
| – | – | 0.01% | 417 |
|
|
2020
Q4 | $229K | Hold |
3,000
| – | – | 0.01% | 396 |
|
|
2020
Q3 | $215K | Hold |
3,000
| – | – | 0.01% | 390 |
|
|
2020
Q2 | $206K | Buy |
+3,000
| New | +$202K | 0.01% | 393 |
|
|
2020
Q1 | – | Sell |
-3,000
| Closed | -$206K | – | 412 |
|
|
2019
Q4 | $206K | Buy |
+3,000
| New | +$195K | 0.01% | 410 |
|
|
2019
Q3 | – | Sell |
-4,000
| Closed | -$247K | – | 422 |
|
|
2019
Q2 | $247K | Hold |
4,000
| – | – | 0.02% | 383 |
|
|
2019
Q1 | $244K | Hold |
4,000
| – | – | 0.02% | 374 |
|
|
2018
Q4 | $227K | Sell |
4,000
-1,000
| -20% | -$59.8K | 0.02% | 336 |
|
|
2018
Q3 | $304K | Buy |
5,000
+850
| +20% | +$51.4K | 0.02% | 288 |
|
|
2018
Q2 | $249K | Sell |
4,150
-4,750
| -53% | -$268K | 0.02% | 343 |
|
|
2018
Q1 | $252K | Buy |
8,900
+4,450
| +100% | +$256K | 0.02% | 328 |
|
|
2017
Q4 | $251K | Hold |
4,450
| – | – | 0.02% | 341 |
|
|
2017
Q3 | $254K | Hold |
4,450
| – | – | 0.03% | 311 |
|
|
2017
Q2 | $242K | Hold |
4,450
| – | – | 0.03% | 314 |
|
|
2017
Q1 | $235K | Hold |
4,450
| – | – | 0.03% | 308 |
|
|
2016
Q4 | $217K | Sell |
4,450
-750
| -14% | -$36K | 0.03% | 309 |
|
|
2016
Q3 | $252K | Hold |
5,200
| – | – | 0.04% | 275 |
|
|
2016
Q2 | $272K | Hold |
5,200
| – | – | 0.04% | 271 |
|
|
2016
Q1 | $250K | Hold |
5,200
| – | – | 0.04% | 266 |
|
|
2015
Q4 | $248K | Sell |
5,200
-600
| -10% | -$30.9K | 0.04% | 255 |
|
|
2015
Q3 | $300K | Hold |
5,800
| – | – | 0.05% | 241 |
|
|
2015
Q2 | $315K | Hold |
5,800
| – | – | 0.06% | 230 |
|
|
2015
Q1 | $319K | Hold |
5,800
| – | – | 0.06% | 234 |
|
|
2014
Q4 | $297K | Hold |
5,800
| – | – | 0.06% | 225 |
|
|
2014
Q3 | $283K | Hold |
5,800
| – | – | 0.06% | 242 |
|
|
2014
Q2 | $274K | Sell |
5,800
-174
| -3% | -$7.99K | 0.06% | 199 |
|
|
2014
Q1 | $272K | Hold |
5,974
| – | – | 0.07% | 185 |
|
|
2013
Q4 | $257K | Hold |
5,974
| – | – | 0.07% | 187 |
|
|
2013
Q3 | $237K | Hold |
5,974
| – | – | 0.07% | 191 |
|
|
2013
Q2 | $222K | Buy |
+5,974
| New | +$228K | 0.07% | 182 |
|
Other funds holding IXJ
PF
Carnegie Investment Counsel's IXJ Position: Q2 2026 in Review
Carnegie Investment Counsel increased its iShares Global Healthcare ETF (IXJ) stake by 19% in Q2 2026, buying an estimated $37.6K and bringing the position to 2,550 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #511.
Carnegie Investment Counsel first reported a position in IXJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $319K in Q1 2015. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.
- Carnegie Investment Counsel held 2,550 shares of iShares Global Healthcare ETF worth $251K as of Q2 2026.
- Carnegie Investment Counsel bought 400 iShares Global Healthcare ETF shares in Q2 2026, an estimated $37.6K.
- iShares Global Healthcare ETF made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #511 holding.
- Carnegie Investment Counsel first reported a position in iShares Global Healthcare ETF in Q2 2013 and has held it in 46 quarters since.
- Carnegie Investment Counsel's iShares Global Healthcare ETF position peaked at $319K in Q1 2015.
- 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.